Skip to main navigation
  • HOME
  • ABOUT ENZON
  • ROYALTY PRODUCTS
  • INVESTORS & MEDIA

    Investor Relations

    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Stock Quote
    • Stock Lookup
    • Contact Us
  • CONTACT US
  • Request Information
  • Email Alerts
  • Download Library
  • RSS News Feeds
Shareholder Tools
Downloads
Print

Downloads

Aug 20, 2007
Enzon to Eliminate Its Remaining 2008 Convertible Debt 12.8 KB
Aug 02, 2007
Enzon Reports Second Quarter 2007 Results 25.7 KB
Aug 01, 2007
Enzon Commences Enrollment of Two Phase 1 Studies of PEG-SN38 for Advanced Solid Tumors and Lymphoma 12.4 KB
Jul 24, 2007
Enzon to Release Earnings on Thursday August 2, 2007; Conference Call and Webcast to Follow 8.1 KB
May 16, 2007
Enzon Stockholders Approve Company Proposals at 2007 Annual Meeting 9.5 KB
May 02, 2007
Enzon Reports First Quarter 2007 Results 26.6 KB
Apr 30, 2007
Enzon Receives FDA Clearance of Its Recently Filed PEG-SN38 IND Application 11.8 KB
Apr 24, 2007
Enzon Announces Timing of Annual Meeting of Shareholders 9.1 KB
Apr 23, 2007
Enzon to Release Earnings on Wednesday May 2, 2007; Conference Call and Webcast to Follow 8.2 KB
Apr 20, 2007
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis 12.9 KB

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Current page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Next page next ›
  • Last page last »

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.